AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives, all while delivering value to our shareholders.
Headquartered in Waltham, Massachusetts, with locations in Tucson, Arizona, and San Bruno, California, our products support the health of patients in the areas of maternal health, anemia management and cancer supportive care. In addition, we help families preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders and have the potential to play a valuable role in the ongoing development of regenerative medicine.
Along with driving organic growth of our products, we seek to leverage our existing commercial infrastructure with additional commercial-stage products in our two current therapeutic areas and may consider late-stage development assets or seek opportunities in new therapeutic areas.
2016 Form 10-K and Proxy Materials
Recent Event Webcasts
AMAG at Deutsche Bank Annual Health Care Conference (Live)
May 03, 2017 at 2:50 p.m. ET
Q1 2017 AMAG Pharmaceuticals, Inc. Earnings Conference Call (Live)
May 02, 2017 at 8:00 a.m. ET
AMAG Pharmaceuticals, Inc. at Needham Healthcare Conference (Replay)
April 04, 2017 at 4:20 p.m. ET